Skip to main content

Advertisement

SpringerLink
Log in

Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China

  • Original Article
  • Published:
Clinical Rheumatology Aims and scope Submit manuscript

Abstract

This study aimed to investigate the associations of anti-C1q antibodies with systemic lupus erythematosus (SLE) disease activity and lupus nephritis (LN) in northeast of China. Ninety patients with SLE, 37 patients with other autoimmune diseases, and 40 healthy donors in northeast of China were enrolled. Serum anti-C1q antibodies were measured by ELISA with 20 RU/ml as the threshold of positive results. The prevalence and levels of anti-C1q antibodies in SLE group (50%, 20.54 ± 34.67 RU/ml) were significantly higher than those in autoimmune disease and healthy control groups (P < 0.05), yet no significant difference between LN patients and non-LN lupus patients (57.14% vs 41.46%, P > 0.05; 25.92 ± 39.94 vs 13.07 ± 27.39 RU/ml, P > 0.05). Anti-C1q antibody levels were positively correlated with levels of Systemic Lupus Erythematosus Disease Activity Index (SLEDAI) scores, anti-dsDNA, and anti-cardiolipin and negatively correlated with serum C3 and C4 (P < 0.05). The prevalence of anti-Sm and anti-nucleosome increased in anti-C1q-positive lupus patients (P < 0.05). Compared with anti-C1q-negative lupus patients, patients with 20–40 RU/ml anti-C1q antibodies had comparable disease activity (P > 0.05); patients with 40–80 RU/ml anti-C1q antibodies had significantly lower levels of serum complement (P < 0.05); patients with above 80 RU/ml anti-C1q antibodies had much more severe hypocomplementemia, increased SLEDAI scores, and higher incidence of hematuria and proteinuria (P < 0.05). Furthermore, the specificity and positive predictive value of 80 RU/ml anti-C1q antibodies for LN was 97.56% and 87.50%, respectively. In conclusion, anti-C1q antibodies are associated with SLE and LN disease activity, and the contribution hinges on the titers. Moreover, high-level anti-C1q antibodies are valuable for diagnosing LN.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Bowness P, Davies KA, Norsworthy PJ et al (1994) Hereditary C1q deficiency and systemic lupus erythematosus. Q J Med 87:455–464

    CAS  Google Scholar 

  2. Oelzner P, Deliyska B, Funfstuck R et al (2003) Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus relationship with disease activity and renal involvement. Clin Rheumatol 22:271–278

    Article  PubMed  CAS  Google Scholar 

  3. Marten T, Margarita LT, Eliaka P et al (2006) High prevalence of anti-C1q antibodies in biopsy-proven active lupus nephritis. Nephrol Dial Transplant 21:3115–3121

    Article  Google Scholar 

  4. Fang QY, Yu F, Tan Y et al (2009) Anti-C1q antibodies and IgG subclass distribution in sera from Chinese patients with lupus nephritis. Nephrol Dial Transplant 24:172–178

    Article  PubMed  CAS  Google Scholar 

  5. Chen PC, Wang CR, Liu MF et al (2002) Correlation between the renal C1q deposition and serum anti-C1q antibody: a potential role of anti-C1q antibody in lupus nephritis. Asian Pac J Allergy Immunol 20:223–227

    PubMed  CAS  Google Scholar 

  6. Hochberg MC (1997) Updating the American College of Rheumatology revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum 40:1725

    Article  PubMed  CAS  Google Scholar 

  7. Li Y (2008) Lupus nephritis. In: Lu ZY, Zhong NS (eds) Internal medicine. People’s Medical, Beijing, pp 863–865

    Google Scholar 

  8. Bombardier C, Gladman DD, Hocherg M (1989) Validity and reliability of six systems for the clinical assessment of disease activity in systemic lupus erythematosus. Arthritis Rheum 32:1107–1118

    Article  Google Scholar 

  9. Bombardier C, Gladman DD, Urowitz MB et al (1992) Derivation of the SLEDAI-A disease activity index for lupus patients. The Committee for Prognosis Studies in SLE. Arthritis Rheum 35:630–640

    Article  PubMed  CAS  Google Scholar 

  10. Siegert C, Daha M, Westedt ML et al (1991) IgG autoantibodies against C1q are correlated with nephritis, dermatitis, hypocomplementemia, and dsDNA antibodies in systemic lupus erythematosus. J Rheumatol 18:230–234

    PubMed  CAS  Google Scholar 

  11. Fremeaux-Bacchi V, Noel LH, Schifferli JA (2002) No lupus nephritis in the absence of antiC1q autoantibodies? Nephrol Dial Transplant 17:2041–2043

    Article  PubMed  CAS  Google Scholar 

  12. Isenberg DA, Ravirajan CT, Rahman A et al (1997) The role of antibodies to DNA in systemic lupus erythematosus—a review and introduction to an international workshop on DNA antibodies held in London May 1996. Lupus 6:290–304

    Article  PubMed  CAS  Google Scholar 

  13. Lloyd W, Schur PH (1981) Immune complexes, complement, and anti-DNA in exacerbations of systemic lupus erythematosus. Medicine (Baltimore) 60:208–217

    CAS  Google Scholar 

  14. Inanc M, Donohoe S, Ravirajan CT et al (1998) Anti-beta2-glycoprotein I, anti-prothrombin and anticardiolipin antibodies in a longitudinal study of patients with systemic lupus erythematosus and the antiphospholipid syndrome. Br J Rheumatol 37:1089–1094

    Article  PubMed  CAS  Google Scholar 

  15. Amoura Z, Piette JC (2003) Role of the nucleosome in the physiopathology of systemic lupus erythematosus. Ann Med Interne (Paris) 154:25–32

    CAS  Google Scholar 

  16. Horvath L, Czirjak L, Fekete B et al (2001) High levels of antibodies against Clq are associated with disease activity and nephritis but not with other organ manifestations in SLE patients. Clin Exp Rheumatol 19:667–672

    PubMed  CAS  Google Scholar 

  17. Siegert CE, Daha MR, Tseng CM et al (1993) Predictive value of IgG autoantibodies against C1q for nephritis in systemic lupus erythematosus. Ann Rheum Dis 52:851–856

    Article  PubMed  CAS  Google Scholar 

  18. Coremans IE, Spronk PE, Boots ma H et al (1995) Changes in antibodies to C1q predict renal relapses in systemic lupus erythematosus. Am J Kidney Dis 26:595–601

    Article  PubMed  CAS  Google Scholar 

  19. Moroni G, Trendeleburg M, Del PN et al (2001) Anti-C1q antibodies may help in diagnosing a renal flare in lupus nephritis. Am J Kidney Dis 37:490–498

    Article  PubMed  CAS  Google Scholar 

  20. Gunnarsson I, Sundelin B, Heimburger M et al (2002) Repeated renal biopsy in proliferative lupus nephritis-predictive role of serum C1q and albuminuria. J Rheumatol 29:693–699

    PubMed  Google Scholar 

  21. Horak P, Hermanova Z, Tichy T et al (2006) C1q complement component and antibodies reflect SLE activity and kidney involvement. Clin Rheumatol 25:532–536

    Article  PubMed  CAS  Google Scholar 

  22. Sinico RA, Radice A, Ikehata M et al (2005) Anti-C1q autoantibodies in lupus nephritis: prevalence and clinical significance. Ann NY Acad Sci 1050:193–200

    Article  PubMed  CAS  Google Scholar 

  23. Botto M, Walport MJ (2002) C1q, autoimmunity and apoptosis. Immunobiology 205:395–406

    Article  PubMed  CAS  Google Scholar 

  24. Barilla-LaBarca ML, Atkinson JP (2003) Rheumatic syndromes associated with complement deficiency. Curr Opin Rheumatol 15:55–60

    Article  PubMed  CAS  Google Scholar 

  25. Pickering MC, Botto M, Aylor PR et al (2000) Systemic lupus erythematosus, complement deficiency and apoptosis. Adv Immunol 76:227–334

    Article  PubMed  CAS  Google Scholar 

  26. Holers VM (2004) Anti-C1q autoantibodies amplify pathogenic complement activation in systemic lupus erythematosus. J Clin Invest 114:616–619

    PubMed  CAS  Google Scholar 

Download references

Disclosures

None

Author information

Authors and Affiliations

  1. Department of Clinical Laboratory, The Second Affiliated Hospital of Harbin Medical University, No. 246 Xue Fu Road, Harbin, 150086, China

    Cai-Qin Zhang, Lei Ren, Fei Gao, Feng-Yun Mu, Yan-Qiu You & Yan-Hong Liu

Authors
  1. Cai-Qin Zhang
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Lei Ren
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Fei Gao
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Feng-Yun Mu
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yan-Qiu You
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Yan-Hong Liu
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Yan-Hong Liu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Zhang, CQ., Ren, L., Gao, F. et al. Anti-C1q antibodies are associated with systemic lupus erythematosus disease activity and lupus nephritis in northeast of China. Clin Rheumatol 30, 967–973 (2011). https://doi.org/10.1007/s10067-011-1698-1

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10067-011-1698-1

Keywords

Search

Navigation